The EVIS X1 includes several new technologies that are aimed to help discover abnormalities, according to a company press release. In one view, called “Red Dichromatic Imaging,” providers will be able to clearly see deep blood vessels and bleeding. Other settings include “Texture and Color Enhancement Imaging,” which the company touts as improved discernment of colors, textures and outlines, and “Brightness Adjustment Imaging with Maintenance of Contrast,” which affects brightness levels.
In addition, the system continues to have “Narrow Band Imaging” technology previously introduced in other Olympus systems, which helps to highlight mucosal surface capillaries and submucosal veins.
The EVIS X1, GIF-1100 and CF-HQ1100DL/I all received FDA clearance in May 2023.
—Natasha Albaneze
